Why the study?
Separate guidelines for acute and chronic heart failure were unrealistic given that acute heart failure is often an exacerbation of chronic heart failure, requiring seamless management.
The 2021 JCS/JHFS guideline update integrates acute and chronic heart failure management to provide a seamless treatment approach.
No takes yet. Share an insight, caveat, or question.
Updates Japanese HF guidelines with multi-society input; extends prior recommendations for acute and chronic management.
A 2021 study conducted a review in Acute and Chronic Heart Failure. Guideline-directed medical therapy was evaluated. The JCS/JHFS 2021 Guideline Focused Update provides updated recommendations for heart failure management, incorporating new evidence for ARNI, SGLT2 inhibitors, and ivabradine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: